Abstract
This study aimed at the preparation and characterization of preformed and in-situ formed liposomes for controlled delivery to the lungs. Two different liposome formulations were prepared and subjected to characterization of physical parameters (vesicle size, appearance, discharge rate, spray pattern and internal pressure) and drug release profile (% cumulative drug release and % drug retained). Formulations were then subjected to accelerated stability studies as per ICH guidelines. It was observed that vesicle size ranged between 2.35 ± 0.23 - 2.41± 0.3 μm and 1.22 ± 0.22- 1.34 ± 0.15 μm respectively for preformed and in-situ formed liposomes. The discharge rate and spray area were in ranges of 110 ± 2.4 -123 ± 2.6 & 115± 2.4 -127±2.3 mg/ actuation & 12.5 ±1.7 -14.1± 2.2 and 13.9 ± 2.1- 14.7± 2.0 cm2 respectively. In-situ liposomes showed better controlled release profile then preformed liposomes as it released 76.5± 2.4 - 58.5 ± 1.8 % drug in 12 hour while retaining 23.5 ± 1.9- 41.5 ± 1.6 % drug whereas preformed liposomes showed cumulative release of 66.5 ± 2.2- 84.5 ± 2.3 % and 15.5 ± 2.4- 33.5± 2.1 % fraction retained. Upon subjection to accelerated conditions for a period of 60 days, preformed liposome completely lost the objective of being controlled release formulation as they showed 92± 2.4 % cumulative release and only 08 ± 1.6 % fraction retained whereas in-situ formulation showed 62 ± 2.3 % cumulative release and 38 ± 2.1 % fraction retained.
Keywords: Tuberculosis, Alveoli, Liposome, Aerosol, Rifampicin, In-situ, Krebs-Henseleit Solution
Current Drug Delivery
Title: In-Situ Formation of Liposome of Rifampicin: Better Availability for Better Treatment
Volume: 6 Issue: 5
Author(s): Praveen Kumar Gaur, Shikha Mishra, V. B. Gupta, M. S. Rathod, Suresh Purohit and Bhavin A. Savla
Affiliation:
Keywords: Tuberculosis, Alveoli, Liposome, Aerosol, Rifampicin, In-situ, Krebs-Henseleit Solution
Abstract: This study aimed at the preparation and characterization of preformed and in-situ formed liposomes for controlled delivery to the lungs. Two different liposome formulations were prepared and subjected to characterization of physical parameters (vesicle size, appearance, discharge rate, spray pattern and internal pressure) and drug release profile (% cumulative drug release and % drug retained). Formulations were then subjected to accelerated stability studies as per ICH guidelines. It was observed that vesicle size ranged between 2.35 ± 0.23 - 2.41± 0.3 μm and 1.22 ± 0.22- 1.34 ± 0.15 μm respectively for preformed and in-situ formed liposomes. The discharge rate and spray area were in ranges of 110 ± 2.4 -123 ± 2.6 & 115± 2.4 -127±2.3 mg/ actuation & 12.5 ±1.7 -14.1± 2.2 and 13.9 ± 2.1- 14.7± 2.0 cm2 respectively. In-situ liposomes showed better controlled release profile then preformed liposomes as it released 76.5± 2.4 - 58.5 ± 1.8 % drug in 12 hour while retaining 23.5 ± 1.9- 41.5 ± 1.6 % drug whereas preformed liposomes showed cumulative release of 66.5 ± 2.2- 84.5 ± 2.3 % and 15.5 ± 2.4- 33.5± 2.1 % fraction retained. Upon subjection to accelerated conditions for a period of 60 days, preformed liposome completely lost the objective of being controlled release formulation as they showed 92± 2.4 % cumulative release and only 08 ± 1.6 % fraction retained whereas in-situ formulation showed 62 ± 2.3 % cumulative release and 38 ± 2.1 % fraction retained.
Export Options
About this article
Cite this article as:
Gaur Kumar Praveen, Mishra Shikha, Gupta B. V., Rathod S. M., Purohit Suresh and Savla A. Bhavin, In-Situ Formation of Liposome of Rifampicin: Better Availability for Better Treatment, Current Drug Delivery 2009; 6 (5) . https://dx.doi.org/10.2174/156720109789941623
DOI https://dx.doi.org/10.2174/156720109789941623 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advancements in Robotic and AI-based Drug Discovery and Delivery for Neurological Disorders
Neurological disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, and brain tumors, pose significant challenges in drug delivery due to the blood-brain barrier's intricate structure and the complexity of neuronal networks. Traditional drug delivery methods often fall short in reaching therapeutic concentrations within the central nervous system, limiting treatment efficacy and ...read more
Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections
Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more
Electrospun Fibers as Drug Delivery Systems
In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more
Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders
Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death
Anti-Cancer Agents in Medicinal Chemistry Third and Fourth Generation Fluoroquinolone Antibacterials: A Systematic Review of Safety and Toxicity Profiles
Current Drug Safety Omega-3 Polyunsaturated Fatty Acids and Cancer
Anti-Cancer Agents in Medicinal Chemistry Clinical Applications of Transcranial Doppler Sonography
Reviews on Recent Clinical Trials p38 MAP Kinase Mediated Proteoglycan Synthesis as a Target for the Prevention of Atherosclerosis
Cardiovascular & Hematological Disorders-Drug Targets Non-Cardiomyocytes in Heart Regeneration
Current Drug Targets Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease
Current Cardiology Reviews Adeno-Associated Viral Vectors for Retinal Gene Transfer and Treatment of Retinal Diseases
Current Gene Therapy The Role of EC-IC Bypass in Critical Cerebral Hemodynamics of Different Origin
Current Hypertension Reviews Therapeutic Applications of Prostaglandins and Thromboxane A2 Inhibitors in Abdominal Aortic Aneurysms
Current Drug Targets Link between Metabolic Syndrome and Insulin Resistance
Current Vascular Pharmacology Matter of Life and Death: the Pharmacological Approaches Targeting Apoptosis in Brain Diseases
Current Pharmaceutical Design Aspartic Proteases of Human Pathogenic Fungi are Prospective Targets for the Generation of Novel and Effective Antifungal Inhibitors
Current Enzyme Inhibition The Calcium-Sensing Receptor as a Regulator of Cellular Fate in Normal and Pathological Conditions
Current Molecular Medicine Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement
Current Pharmaceutical Design Purinergic Receptors and Pain
Current Pharmaceutical Design Oxidative Stress and Endothelial Dysfunction: Say NO to Cigarette Smoking!
Current Pharmaceutical Design Drug Target Identification in Intracellular and Extracellular Protozoan Parasites
Current Topics in Medicinal Chemistry Cardiovascular Magnetic Resonance T2-weighted Imaging of Myocardial Edema in Acute Myocardial Infarction
Recent Patents on Cardiovascular Drug Discovery Nanotechnology and Atherosclerosis Imaging: Emerging Diagnostic and Therapeutic Applications
Recent Patents on Cardiovascular Drug Discovery